[SYRS] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
14-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -17.87%
YoY- -67.40%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 0 1,101 317 0 0 0 0 -
PBT -13,368 -11,515 -10,965 -14,169 -12,021 -10,588 -10,689 16.09%
Tax 0 0 0 0 0 0 0 -
NP -13,368 -11,515 -10,965 -14,169 -12,021 -10,588 -10,689 16.09%
Tax Rate - - - - - - - -
Total Cost 13,368 12,616 11,282 14,169 12,021 10,588 10,689 16.09%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.00 -1,045.87 -3,458.99 0.00 0.00 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -5.23 -4.92 -4.69 -6.44 -47.08 -4.65 -5.96 -8.34%
EPS Diluted -5.23 -4.92 -4.69 -6.44 -47.08 -4.65 -5.96 -8.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.